Amgen Inc.

8-K Item 1.05 Jul 31, 2026 8-K Shareholder vote results May 20, 2026 8-K Director or officer change May 19, 2026 10-Q Quarter ended 2026-03-31 May 1, 2026 8-K Results of operations (earnings release) Apr 30, 2026 8-K Director or officer change Apr 22, 2026 8-K Entered a material agreement Feb 19, 2026 10-K Fiscal year ended 2025-12-31 Feb 13, 2026 8-K Results of operations (earnings release) Feb 3, 2026 8-K Terminated a material agreement Jan 30, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 4, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Shareholder vote results May 27, 2025 10-Q Quarter ended 2025-03-31 May 2, 2025 8-K Results of operations (earnings release) May 1, 2025 10-K Fiscal year ended 2024-12-31 Feb 14, 2025 8-K Results of operations (earnings release) Feb 4, 2025 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Results of operations (earnings release) Oct 30, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Director or officer change; Shareholder vote results Jun 3, 2024 10-Q Quarter ended 2024-03-31 May 3, 2024 8-K Results of operations (earnings release) May 2, 2024 10-K Fiscal year ended 2023-12-31 Feb 14, 2024 8-K Results of operations (earnings release) Feb 6, 2024 8-K Director or officer change Dec 14, 2023 10-Q Quarter ended 2023-09-30 Oct 31, 2023 8-K Results of operations (earnings release) Oct 31, 2023 8-K Completed an acquisition or disposition; Took on a direct financial obligation; Regulation FD disclosure Oct 6, 2023 8-K Other events Oct 5, 2023 8-K Other events Sep 12, 2023 8-K Other events Sep 5, 2023 8-K Regulation FD disclosure; Other events Sep 1, 2023 10-Q Quarter ended 2023-06-30 Aug 4, 2023 8-K Director or officer change Aug 4, 2023 8-K Results of operations (earnings release) Aug 3, 2023 8-K Other events Jun 5, 2023